Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment-Reference-Cited by-同舟云学术

Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment

Published:2017-11-06 Issue:1 Volume:36 Page:7-15
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Beca Jaclyn,Husereau Don^ORCID,Chan Kelvin K. W.,Hawkins Neil,Hoch Jeffrey S.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/article/10.1007/s40273-017-0583-4/fulltext.html

Reference46 articles.

1. Mathes T, Jacobs E, Morfeld J-C, Pieper D. Methods of international health technology assessment agencies for economic evaluations: a comparative analysis. BMC Health Serv Res. 2013;13:371.

2. Tsoi B, Masucci L, Campbell K, Drummond M, O’Reilly D, Goeree R. Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiences. Expert Rev Pharmacoecon Outcomes Res. 2013;13:497–511.

3. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: Oxford University Press; 2015.

4. Caro JJ, Briggs AH, Siebert U, Kuntz KM. ISPOR-SMDM modeling good research practices task force. Modeling good research practices: overview. A report of the ISPOR-SMDM modeling good research practices task force: 1. Value Health. 2012;15:796–803.

5. Hoch JS, Beca J, Sabharwal M, Livingstone SW, Fields ALA. Does it matter whether Canada’s separate health technology assessment process for cancer drugs has an economic rationale? Pharmacoeconomics. 2015;33:879–82.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ‘Managing values’ in health economics modelling: Philosophical and practical considerations;Social Science & Medicine;2024-10

2. Making Decision Models Fit for Purpose: The Importance of Ensuring Stakeholder Involvement;PharmacoEconomics;2024-01-18

3. INES: Interactive tool for construction and extrapolation of partitioned survival models;Cost Effectiveness and Resource Allocation;2023-07-31

4. INES: INteractive tool for construction and Extrapolation of partitioned Survival models;2023-05-08

5. Promoting confidence in cost-effectiveness analyses;BMJ;2022-06-22